| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (2005) |
32 |
128 |
0.25 － 128 |
Gentamicin (Gentamycin, Garamycin)  |
907 |
| Staphylococcus aureus (2005) |
128 |
128 |
≤0.06 － 128 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
907 |
| Staphylococcus aureus (209 P) |
- |
- |
100 － ? |
FR-900848 |
1169 |
| Staphylococcus aureus (209P IFO 12732) |
- |
- |
3 － ? |
Licochalcone A |
184 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.025 － ? |
Tosufloxacin |
963 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.1 － ? |
Clarithromycin (Biaxin) |
421 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.2 － ? |
Amoxicillin (Novamox, Amoxil) |
421 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
963 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.39 － ? |
Norfloxacin (Noroxin) |
963 |
| Staphylococcus aureus (209P JC) |
- |
- |
0.39 － ? |
Ofloxacin (Floxin) |
963 |
| Staphylococcus aureus (209P JC) |
- |
- |
>25 － ? |
TG44 |
421 |
| Staphylococcus aureus (209P JC) |
- |
- |
>200 － ? |
Metronidazole (Flagyl) |
421 |
| Staphylococcus aureus (209-P JC) |
- |
- |
0.04 － ? |
dideoxy-Kanamycin B |
1501 |
| Staphylococcus aureus (209P JC-1) |
- |
- |
<0.025 － ? |
Imipenem |
1272 |
| Staphylococcus aureus (209P) |
- |
- |
0.2 － ? |
Arbekacin |
730 |
| Staphylococcus aureus (209P) |
- |
- |
0.39 － ? |
2"-amino-2"-deoxyarbekacin |
730 |
| Staphylococcus aureus (209P-JC) |
- |
- |
0.1 － ? |
Clarithromycin (Biaxin) |
380 |
| Staphylococcus aureus (226) |
- |
- |
128 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
264 |
| Staphylococcus aureus (241 + methicillin-resistant) |
- |
- |
0.5 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
224 |
| Staphylococcus aureus (241 + methicillin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
224 |
| Staphylococcus aureus (241) |
- |
- |
64 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
78 |
| Staphylococcus aureus (249189 + methicillin-susceptible) |
- |
- |
0.5 － ? |
PH-027 |
193 |
| Staphylococcus aureus (249189 + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
193 |
| Staphylococcus aureus (249189 + methicillin-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
193 |
| Staphylococcus aureus (25-670 + initial) |
- |
- |
0.06 － ? |
REP8839 |
789 |
| Staphylococcus aureus (25-670 + initial) |
- |
- |
2048 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (25-670 + serial passage) |
- |
- |
4 － ? |
REP8839 |
789 |
| Staphylococcus aureus (25-670 + serial passage) |
- |
- |
4 － ? |
REP8839 |
789 |